AstraZeneca Inks $247M AI-Enabled Oncology Antibody Design Pact, Joining Absci’s List of Pharma Allies

Jun 10, 2026

Fierce Biotech coverage of AstraZeneca’s $247M deal with Absci for AI-enabled oncology antibody design.